AdvanSix, Inc. Aktie News

AdvanSix is rated a Buy, offering deep value at under 7.1x P/E and a conservative price target of $30/share. ASIX's fundamentals remain strong despite recent volatility, with stable earnings, a well-covered 3.29% dividend, and significant upside from carbon capture tax credits. Risks stem from ASIX's small size and sector cyclicality, but most operational instability is now resolved, supporting...

PARSIPPANY, N.J.--(BUSINESS WIRE)--AdvanSix To Release Third Quarter Financial Results And Hold Investor Conference Call On November 7.

PARSIPPANY, N.J.--(BUSINESS WIRE)--AdvanSix Appoints Dana O'Brien And Daryl Roberts To Board Of Directors.

AdvanSix (ASIX -4.62%), a U.S.-based producer of essential chemicals, released results on August 1, 2025, covering the three months ended June 30. The headline was a mixed performance: adjusted diluted earnings per share (Non-GAAP) came in at $1.24, beating the $1.185 analyst estimate by 4.6%, but revenue (GAAP) of $410 million missed expectations, coming in 4.3% below the $428.4 million GAAP c...

AdvanSix Inc. (NYSE:ASIX ) Q2 2025 Earnings Conference Call August 1, 2025 9:30 AM ET Company Participants Adam Kressel - VP of Investor Relations & Treasurer Christopher Gramm - Vice President of Financial Planning and Analysis & Interim CFO Erin N. Kane - CEO, President & Director Conference Call Participants Operator Good morning, and welcome to the AdvanSix Second Quarter 2025 Earnings Conf...

PARSIPPANY, N.J.--(BUSINESS WIRE)--AdvanSix Announces Second Quarter 2025 Financial Results.

PARSIPPANY, N.J.--(BUSINESS WIRE)--AdvanSix To Release Second Quarter Financial Results And Hold Investor Conference Call On August 1.

AdvanSix is undervalued, trading at low multiples due to sector cyclicality, but the market underestimates its risk/return profile and SUSTAIN project's impact. The SUSTAIN project, with a projected 30% IRR and regulatory protection, shifts focus to less-cyclical plant nutrients, reducing earnings volatility and supporting higher valuation. I see potential for the stock to re-rate to 7x EV/EBIT...